Pulmonary Delivery of Nanoparticle-Bound Toll-like Receptor 9 Agonist for the Treatment of Metastatic Lung Cancer-Reference-Cited by-同舟云学术

Pulmonary Delivery of Nanoparticle-Bound Toll-like Receptor 9 Agonist for the Treatment of Metastatic Lung Cancer

Published:2020-05-28 Issue:6 Volume:14 Page:7200-7215
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Perry Jillian L.^ORCID,Tian Shaomin,Sengottuvel Nisitha,Harrison Emily B.,Gorentla Balachandra K.,Kapadia Chintan H.,Cheng Ning,Luft J. Christopher,Ting Jenny P.-Y.¹,DeSimone Joseph M.¹^ORCID,Pecot Chad V.

Affiliation:

1. Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina 27695, United States

Funder

National Cancer Institute

Lineberger Comprehensive Cancer Center, University of North Carolina

Free To Breathe

University of North Carolina at Chapel Hill

American Cancer Society

V Foundation for Cancer Research

Lung Cancer Research Foundation

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.0c02207

Reference53 articles.

1. Non–Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy

2. Implementation of immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)

3. Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes

4. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advance of nanotechnology in diagnosis and treatment for malignant tumors;Signal Transduction and Targeted Therapy;2024-08-12

2. Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy;Journal of Controlled Release;2024-08

3. Natural Killer-Based Therapy: A Prospective Thought for Cancer Treatment Related to Diversified Drug Delivery Pathways;Pharmaceutics;2024-07-14

4. Inhalable metal–organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy;Acta Pharmaceutica Sinica B;2024-05

5. Targeted chemotherapy via HER2-based chimeric antigen receptor (CAR) engineered T-cell membrane coated polymeric nanoparticles;Bioactive Materials;2024-04